Enjoy complimentary customisation on priority with our Enterprise License!
The cytology market size growth is expected to progress at a CAGR of 6.98 % and is estimated to be USD 1.98 billion from 2021 to 2026.
The cytology market has been broadly categorized into the following demographic segmentations:
The cytology market vendors covered in this market study include Abbott Laboratories, Agilent Technologies Inc., Arbor Vita Corp., Becton Dickinson and Co., Bio Optica Milano Spa, CellPath Ltd., Danaher Corp., Diapath S.p.A., F. Hoffmann La Roche Ltd., HiMedia Laboratories Pvt. Ltd., Hologic Inc., Merck KGaA, PerkinElmer Inc., Poly Scientific R and D Corp., Polysciences Inc., Promega Corp., Southwest Precision Instruments LLC, Sysmex Corp., Thermo Fisher Scientific Inc., and Trivitron Healthcare among others. One of the key highlights of the cytology industry research report is the post COVID-19 impact analysis on the market, which will help companies evaluate their business approaches for the forecast period.
Download the Free Report Sample to Unlock the Cytology Market Size for the Forecast Period and Other Important Statistics
The growing cervical cancer screening awareness is notably driving the cytology market growth, although factors such as factors affecting the adequacy of tests may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the cytology industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Cytology Market Driver
One of the key factors driving the global cytology industry growth is the growing cervical cancer screening awareness owing to favorable initiatives by the government as well as NGOs. Globally, an estimated 604,127 women were diagnosed with cervical cancer in 2020. Also, the treatment costs accounted for USD 2 billion per year for cervical cancer in the US. Thus, in countries such as India, Pink Chain Campaigns are launched to raise awareness about the spread of cervical cancer. Similarly, in Australia, cervical cancer stands third most commonly diagnosed gynecological cancer in women. CDC's National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provides screening and diagnostic services for breast and cervical cancer to low-income, underinsured, and uninsured women across the US. Such initiatives will increase the awareness among the people, thereby fueling the market during the forecast period.
Key Cytology Market Trend
One of the key cytology market trends that is expected to impact the industry positively in the forecast years is the growing popularity of co-testing, as it is more sensitive in detecting high-grade dysplasia and cost-effective. In addition, the increasing prevalence of HPV-associated cancers is projected to drive the market. For instance, according to CDC, from 2014 to 2018, about 46,143 HPV-associated cancers occurred in the US, out of which about 25,719 were diagnosed in women and about 20,424 were among men. Thus, screening initiatives for cervical cancers help in the early detection of HPV infected cells and, therefore, can be effectively treated. For instance, in the UK, UK National Screening Committee (NSC) is responsible for screening and assessing the evidence and making recommendations to the government of England, Northern Ireland, Scotland, and Wales, about the screening program.
Key Cytology Market Challenge
One of the key challenges to the global cytology industry growth is the factors affecting the adequacy of tests such as air-drying artifacts, diagnostic pitfalls, and false-negative results. Air dying artifacts give a false impression of enlargement of cells and nuclei. Furthermore, poor fixation techniques, inflammatory changes, and cellular changes related to radiation may obscure cellular details and misinterpret the result. In addition, false-positive diagnosis can occur in case of pregnancy, contamination of the sample, inflammation, presence of hemorrhage, and inexperienced pathologist. Such factors will affect the adequacy of the test result and hence negatively affect the market growth in the coming years.
This cytology market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
Technavio categorizes the global cytology market as a part of the global healthcare equipment market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the cytology market during the forecast period.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
This statistical study of the cytology market encompasses successful business strategies deployed by the key vendors. The cytology market is fragmented and the growth strategies adopted by vendors to compete in the market are :
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The cytology market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Our report provides extensive information on the value chain analysis for the cytology market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chain is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
For more insights on the market share of various regions Request for a FREE sample now!
37% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for cytology in North America. However, market growth in this region will be slower than the growth of the market in other regions.
The presence of major companies such as Abbott, BD, Thermo Fisher Scientific, and Hologic and the significant increase in the investment in R and D will facilitate the cytology market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
The regional cytology market witnessed a slowdown in 2020 due to the outbreak of COVID-19. The US has been the most affected country globally by the COVID-19 pandemic. Many industries were adversely affected by the outbreak. However, by 2021, the demand for cytology testing rebounded as regional end-user activities picked up due to the initiation of large-scale COVID-19 vaccination drives. These factors will, thus, drive the growth of the regional cytology market during the forecast period.
To gain further insights on the market contribution of various segments Request for a FREE sample
The cytology market share growth by the hospitals segment will be significant during the forecast period. The significant increase in the number of hospitals in India, Malaysia, Brazil, China, and other developing countries owing to the increasing need for acute and critical care and the growing trend of medical tourism, will drive the market growth in the coming years.
This report provides an accurate prediction of the contribution of all the segments to the growth of the cytology market size and actionable market insights on post COVID-19 impact on each segment.
Cytology Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 6.98% |
Market growth 2022-2026 |
$ 1.98 billion |
Market structure |
Fragmented |
YoY growth (%) |
6.6 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 37% |
Key consumer countries |
US, Canada, UK, Germany, Japan, and China |
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
Key companies profiled |
Abbott Laboratories, Agilent Technologies Inc., Arbor Vita Corp., Becton Dickinson and Co., Bio Optica Milano Spa, CellPath Ltd., Danaher Corp., Diapath S.p.A., F. Hoffmann La Roche Ltd., HiMedia Laboratories Pvt. Ltd., Hologic Inc., Merck KGaA, PerkinElmer Inc., Poly Scientific R and D Corp., Polysciences Inc., Promega Corp., Southwest Precision Instruments LLC, Sysmex Corp., Thermo Fisher Scientific Inc., and Trivitron Healthcare |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Five Forces Analysis
5 Market Segmentation by End-user
6 Customer Landscape
7 Geographic Landscape
8 Drivers, Challenges, and Trends
9 Vendor Landscape
10 Vendor Analysis
11 Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.